Jürgen Krauter

机构：Klinikum Braunschweig

发表论文 259 篇 · 总被引 16547 次 · h-index 59

代表论文

• Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09–09): a randomised, open-label, multicentre, phase 3 trial (2023 · The Lancet Haematology · 被引 59)
• Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study (2023 · Blood Advances · 被引 28)
• Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study (2024 · British Journal of Haematology · 被引 21)
• 10 Year Follow-up of CALGB 10603/Ratify: Midostaurin Versus Placebo Plus Intensive Chemotherapy in Newly Diagnosed FLT3 Mutant Acute Myeloid Leukemia Patients Aged 18-60 Years (2024 · Blood · 被引 12)
• Olutasidenib for mutated IDH1 acute myeloid leukemia: final five-year results from the phase 2 pivotal cohort (2025 · Journal of Hematology & Oncology · 被引 9)
• Prognostic impact of clonal representation of myelodysplasia-related gene mutations in acute myeloid leukemia (2025 · Leukemia · 被引 8)